Related Experiment Video

Updated: May 31, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

Breast cancer vaccines: ongoing National Cancer Institute-registered clinical trials

Elizabeth A Mittendorf1, Gheath Alatrash, Haile Xiao

  • 1Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Expert Review of Vaccines
|June 23, 2011
PubMed

Insights

Breast cancer vaccines show promise as targeted therapies. This review highlights delivery platforms, antigens, and strategies to improve vaccine efficacy in ongoing clinical trials.

Area of Science:

  • Oncology
  • Immunology
  • Vaccine Development

Background:

  • Molecular tumor characterization drives interest in targeted cancer therapies, including vaccines.
  • Sipuleucel-T's success in prostate cancer indicates potential for cellular vaccines in solid tumors.

Purpose of the Study:

  • Focus on breast cancer vaccines.
  • Emphasize delivery platforms, target antigens, and novel strategies.
  • Review ongoing Phase II clinical trials evaluating these vaccines.

Main Methods:

  • Literature review of breast cancer vaccine research.
  • Analysis of delivery systems (e.g., viral, bacterial, dendritic cell-based).
  • Identification of key target antigens and immune-enhancing strategies.

Main Results:

  • Several delivery platforms are under investigation for breast cancer vaccines.
  • Specific target antigens are being explored to elicit anti-tumor immune responses.
  • Novel strategies aim to overcome immune tolerance and enhance vaccine effectiveness.

Conclusions:

  • Breast cancer vaccines represent a promising avenue for targeted therapy.
  • Ongoing clinical trials are crucial for evaluating efficacy and optimizing treatment strategies.
  • Further research into delivery, antigens, and immune modulation will advance vaccine development.

More Related Videos

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer08:26

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer

Published on: March 24, 2013

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...